TransMedics Group (NASDAQ:TMDX – Free Report) had its price target boosted by Canaccord Genuity Group from $102.00 to $117.00 in a research report report published on Wednesday, Benzinga reports. They currently have a buy rating on the stock. Other equities analysts also recently issued reports about the company. Morgan Stanley lifted their target price on […]